Adding Taxotere To Chemotherapy Regimen Improves Survival In Early Breast Cancer, Study Suggests

For patients with early stage breast cancer that has spread to the lymph nodes, adding four cycles of docetaxel (Taxotere) into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show.

Read the whole article on Science Daily

More from Science Daily